Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson’s Disease Dementia

Circadian and Sleep Dysfunctions in Neurodegenerative Disorders—An Update

(2021) Karim Fifel et al.   Frontiers in Neuroscience

Glucose, glycolysis, and neurodegenerative diseases

(2020) Bor Luen Tang   JOURNAL OF CELLULAR PHYSIOLOGY

Clinical and Imaging Markers of Prodromal Parkinson's Disease

(2020) Eldbjørg Hustad et al.   Frontiers in Neurology

The Role of Neuropsychiatric Symptoms in Research Diagnostic Criteria for Neurodegenerative Diseases

(2020) Jeffrey Cummings   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Cerebral deficiency of vitamin B5 (d-pantothenic acid; pantothenate) as a potentially-reversible cause of neurodegeneration and dementia in sporadic Alzheimer’s disease

(2020) Jingshu Xu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Parkinson’s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions

(2020) Federico Baldini et al.   BMC BIOLOGY

Gut Microbiota and Metabolome Alterations Associated with Parkinson’s Disease

(2020) Sarah Vascellari et al.   mSystems

Alpha-Synuclein Pathology and the Role of the Microbiota in Parkinson’s Disease

(2019) Emily Fitzgerald et al.   Frontiers in Neuroscience

Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats

(2019) Nathalie Van Den Berge et al.   ACTA NEUROPATHOLOGICA

Cerebral Vitamin B5 (D-Pantothenic Acid) Deficiency as a Potential Cause of Metabolic Perturbation and Neurodegeneration in Huntington’s Disease

(2019) Stefano Patassini et al.   Metabolites

Vitamin B5 (d-pantothenic acid) localizes in myelinated structures of the rat brain: Potential role for cerebral vitamin B5 stores in local myelin homeostasis

(2019) Nashwah Ismail et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Glycolysis as a therapeutic target for Parkinson's disease

(2019) Thomas Foltynie   LANCET NEUROLOGY

To stage, or not to stage

(2019) Kelly Del Tredici et al.   CURRENT OPINION IN NEUROBIOLOGY

Evidence for brain glucose dysregulation in Alzheimer's disease

(2018) Yang An et al.   Alzheimers & Dementia

Metabolomic investigations in cerebrospinal fluid of Parkinson's disease

(2018) Desiree Willkommen et al.   PLoS One

The Gut and Parkinson’s Disease: Hype or Hope?

(2018) Filip Scheperjans et al.   Journal of Parkinsons Disease

FDG-PET hypometabolism is more sensitive than MRI atrophy in Parkinson's disease: A whole-brain multimodal imaging meta-analysis

(2018) Franziska Albrecht et al.   NeuroImage-Clinical

Huntington's disease: a clinical review

(2017) P. McColgan et al.   EUROPEAN JOURNAL OF NEUROLOGY

Meta-Analysis of Parkinson’s Disease and Alzheimer’s Disease Revealed Commonly Impaired Pathways and Dysregulation of NRF2-Dependent Genes

(2017) Qian Wang et al.   JOURNAL OF ALZHEIMERS DISEASE

Cerebellar atrophy in neurodegeneration—a meta-analysis

(2017) Helena M Gellersen et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Rating scales for cognition in Huntington's disease: Critique and recommendations

(2017) Tiago A. Mestre et al.   MOVEMENT DISORDERS

Brain urea increase is an early Huntington’s disease pathogenic event observed in a prodromal transgenic sheep model and HD cases

(2017) Renee R. Handley et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Exploring Braak’s Hypothesis of Parkinson’s Disease

(2017) Carmen D. Rietdijk et al.   Frontiers in Neurology

Impaired synaptic function is linked to cognition in Parkinson's disease

(2017) Per Selnes et al.   Annals of Clinical and Translational Neurology

Metabolite mapping reveals severe widespread perturbation of multiple metabolic processes in Huntington's disease human brain

(2016) Stefano Patassini et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Graded perturbations of metabolism in multiple regions of human brain in Alzheimer's disease: Snapshot of a pervasive metabolic disorder

(2016) Jingshu Xu et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Gait variability in people with neurological disorders: A systematic review and meta-analysis

(2016) Yaejin Moon et al.   HUMAN MOVEMENT SCIENCE

Elevation of brain glucose and polyol-pathway intermediates with accompanying brain-copper deficiency in patients with Alzheimer’s disease: metabolic basis for dementia

(2016) Jingshu Xu et al.   Scientific Reports

Identification of elevated urea as a severe, ubiquitous metabolic defect in the brain of patients with Huntington's disease

(2015) Stefano Patassini et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Deregulation of purine metabolism in Alzheimer's disease

(2015) Belén Ansoleaga et al.   NEUROBIOLOGY OF AGING

Brain-gut-microbiota axis in Parkinson's disease

(2015) Agata Mulak   WORLD JOURNAL OF GASTROENTEROLOGY

Defective pantothenate metabolism and neurodegeneration

(2014) Susan J. Hayflick   BIOCHEMICAL SOCIETY TRANSACTIONS

Grey matter hypometabolism and atrophy in Parkinson’s disease with cognitive impairment: a two-step process

(2014) Rafael González-Redondo et al.   BRAIN

The cerebellum in Parkinson’s disease

(2013) Tao Wu et al.   BRAIN

The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort

(2013) Caroline H Williams-Gray et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Alzheimer’s disease: amino acid levels and brain metabolic status

(2013) Maria Concetta Gueli et al.   NEUROLOGICAL SCIENCES

Cerebral Glucose Metabolic Features of Parkinson Disease and Incident Dementia: Longitudinal Study

(2011) N. I. Bohnen et al.   JOURNAL OF NUCLEAR MEDICINE

The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years

(2008) Mariese A. Hely et al.   MOVEMENT DISORDERS